Rottenstein Law Group Recommends Medical Consultation Notwithstanding Recent Suggestion That Fosamax Benefits Outweigh Risks

Share Article

The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the drug Fosamax, notes that a recent article in a well-regarded publication seems to conclude that Fosamax is more beneficial than detrimental, but advises users of the drug to speak to doctors to be certain that are not in danger.

The Rottenstein Law Group, LLP

Earlier this month, the New England Journal of Medicine published a study showing a connection between osteoporosis drugs such as Fosamax, Boniva, and Actonel (each a bisphosphonate) with an increased risk of a rare type of atypical bone fracture that affects the femur.

Data from 12,777 women aged 55 and older indicated that 1,271 suffered from osteoporosis fractures, according to the NEJM article. Of these, 59 had an atypical femur fracture. Approximately 78 percent of those women had taken a bisphosphonate. The study found a connection between osteoporosis drugs and fractures, yet the researchers noted that the risk was “limited” and did not outweigh the benefits of the drugs.

"These population-based nationwide analyses may be reassuring for patients who receive bisphosphonates," wrote lead researcher Dr. Per Aspenberg. "Although there was a high prevalence of current bisphosphonate use among patients with atypical fractures, the absolute risk was small." Dr. Aspenberg also commented that for every one atypical fracture caused by bisphosphonates, the drugs protected 50 to 60 patients from more common osteoporosis fractures.

Despite being the most popular osteoporosis treatment medication on the market, Fosamax has been linked to several serious side effects. In 2004, researchers found a causal connection between Fosamax and osteonecrosis of the jaw, a condition where the jawbone dies due to a lack of blood supply. More recently, people have suffered low-impact femur fractures after falling from standing height or less. Evidence is building that taking Fosamax or similar medications for the treatment of osteoporosis causes a dramatic increase in risk of this particular kind of rare fracture to the thigh bone. Some doctors are now recommending that patients take a break from taking Fosamax or other bisphosphonate drugs after as few as five or as many as ten years of treatment.

The Rottenstein Law Group urges anyone whose friend or relative has been prescribed Fosamax or another osteoporosis drug to reach out to that person and recommend that he or she consult a physician immediately and then speak to a qualified personal injury lawyer. The Rottenstein Law Group maintains a Fosamax Fracture Lawsuit Information Center at The site has features that allow for easy sharing, including links for automatic posting on Facebook and Twitter, specifically to enable visitors to spread the word about the dangers of Fosamax.

The Rottenstein Law Group is a New York-based law firm that represents clients in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients in consumer product injury, mass tort, and class action lawsuits in a compassionate manner.

The Rottenstein Law Group, LLP
Rochelle Rottenstein, Esq.
1259 Veeder Drive
Hewlett NY 11557
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Rochelle Rottenstein, Esq.
Visit website